Advances in reducing cardiovascular risk in the management of patients with type 2 diabetes mellitus

Treatment intended to lower cardiovascular (CV) risk in patients with diabetes has always been a primary goal of diabetes treatment. Due to the subdued effects of reducing hemoglobin A1c (HbA1c) on macrovascular complications, controlling other CV risk factors such as hypertension and hyperlipidemia...

Full description

Bibliographic Details
Main Author: Ying Hu
Format: Article
Published: KeAi Communications Co., Ltd. 2019-03-01
Series:Chronic Diseases and Translational Medicine
Online Access: